1. Academic Validation
  2. High Affinity Agonists of the Neuropeptide Y (NPY) Y4 Receptor Derived from the C-Terminal Pentapeptide of Human Pancreatic Polypeptide (hPP): Synthesis, Stereochemical Discrimination, and Radiolabeling

High Affinity Agonists of the Neuropeptide Y (NPY) Y4 Receptor Derived from the C-Terminal Pentapeptide of Human Pancreatic Polypeptide (hPP): Synthesis, Stereochemical Discrimination, and Radiolabeling

  • J Med Chem. 2016 Jul 14;59(13):6045-58. doi: 10.1021/acs.jmedchem.6b00309.
Kilian K Kuhn 1 Thomas Ertl 2 Stefanie Dukorn 1 Max Keller 1 Günther Bernhardt 1 Oliver Reiser 2 Armin Buschauer 1
Affiliations

Affiliations

  • 1 Institute of Pharmacy, University of Regensburg , Universitätsstraße 31, 93053 Regensburg, Germany.
  • 2 Institute of Organic Chemistry, University of Regensburg , Universitätsstraße 31, 93053 Regensburg, Germany.
Abstract

The diastereomeric mixture of d/l-2,7-diaminooctanedioyl-bis(YRLRY-NH2) (BVD-74D, 2) was described in the literature as a high affinity Y4 receptor agonist. Here we report on the synthesis and pharmacological characterization of the pure diastereomers (2R,7R)- and (2S,7S)-2 and a series of homo- and heterodimeric analogues in which octanedioic acid was used as an achiral linker. To investigate the role of the Arg residues, one or two arginines were replaced by Ala. Moreover, N(ω)-(6-aminohexylaminocarbonyl)Arg was introduced as an arginine replacement (17). (2R,7R)-2 was superior to (2S,7S)-2 in binding and functional cellular assays and equipotent with 17. [(3)H]Propionylation of one amino group in the linker of (2R,7R)-2 or at the primary amino group in 17 resulted in high affinity Y4R radioligands ([(3)H]-(2R,7R)-10, [(3)H]18) with subnanomolar Kd values.

Figures